MeSH term
Frequency | Condition_Probility | Animals | 12 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
*Chromosomes, Human, Pair 1 | 4 | 0.0 |
Genetic Markers | 2 | 0.0 |
Humans | 20 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 21 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Swine/*genetics | 2 | 1.0 |
Endothelial Growth Factors/biosynthesis | 2 | 3.0 |
Gene Expression | 2 | 0.0 |
Lymphokines/biosynthesis | 2 | 1.0 |
Mice | 7 | 0.0 |
Mice, Knockout | 4 | 0.0 |
Vascular Endothelial Growth Factor A | 2 | 0.0 |
Vascular Endothelial Growth Factors | 2 | 0.0 |
Alleles | 2 | 0.0 |
Female | 10 | 0.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
Isoenzymes/*genetics | 3 | 0.0 |
Male | 10 | 0.0 |
Middle Aged | 6 | 0.0 |
Prostaglandin-Endoperoxide Synthase/*genetics | 5 | 17.0 |
Research Support, U.S. Gov't, P.H.S. | 8 | 0.0 |
Adult | 5 | 0.0 |
Aged | 5 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
CpG Islands/genetics | 2 | 1.0 |
*DNA Methylation | 3 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Base Sequence | 6 | 0.0 |
Gene Expression Regulation/*drug effects | 2 | 0.0 |
Molecular Sequence Data | 4 | 0.0 |
Case-Control Studies | 2 | 0.0 |
Genotype | 3 | 0.0 |
Gene Frequency | 3 | 0.0 |
*Polymorphism, Single Nucleotide | 3 | 0.0 |
Haplotypes | 3 | 0.0 |
Time Factors | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Prognosis | 2 | 0.0 |
Comparative Study | 3 | 0.0 |
DNA Primers | 2 | 0.0 |
Cells, Cultured | 2 | 0.0 |
